Eximia Research Network acquires Tidewater Clinical Research
Eximia Research Network has announced the acquisition of Tidewater Clinical Research, marking a significant expansion of its national clinical trial site network.
Established in 1994, Tidewater Clinical Research focuses on Women’s Health and Ophthalmology clinical trials in the Hampton Roads/Eastern Virginia region in the US.
The integration of Tidewater’s capabilities and patient database with Eximia’s extensive resources is expected to enhance clinical trial experiences.
Tidewater owner Kelley Fleming said: “Tidewater Clinical Research is proud to announce our integration into the Eximia Research Network, marking a significant step forward in enhancing clinical research accessibility and quality of care for diverse patient populations.”
Tidewater co-owner April Rusch said: “Under the Eximia umbrella, Tidewater is poised to broaden its impact on patient health and contribute to the advancement of medical research in ever-expanding medical subspecialty areas.”
For the transaction, David Bogart and Devak Patel from Viking Mergers & Acquisitions served as advisers.
August 7, 2024
